These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

228 related items for PubMed ID: 7508690

  • 21. Isobutyramide, an orally bioavailable butyrate analogue, stimulates fetal globin gene expression in vitro and in vivo.
    Perrine SP, Dover GH, Daftari P, Walsh CT, Jin Y, Mays A, Faller DV.
    Br J Haematol; 1994 Nov; 88(3):555-61. PubMed ID: 7529533
    [Abstract] [Full Text] [Related]

  • 22. Sodium butyrate enhances fetal globin gene expression in erythroid progenitors of patients with Hb SS and beta thalassemia.
    Perrine SP, Miller BA, Faller DV, Cohen RA, Vichinsky EP, Hurst D, Lubin BH, Papayannopoulou T.
    Blood; 1989 Jul; 74(1):454-9. PubMed ID: 2473801
    [Abstract] [Full Text] [Related]

  • 23. Differences in response to fetal hemoglobin induction therapy in beta-thalassemia and sickle cell disease.
    Fathallah H, Taher A, Bazarbachi A, Atweh GF.
    Blood Cells Mol Dis; 2009 Jul; 43(1):58-62. PubMed ID: 19346141
    [Abstract] [Full Text] [Related]

  • 24. Role of intergenic human gamma-delta-globin sequences in human hemoglobin switching and reactivation of fetal hemoglobin in adult erythroid cells.
    Bank A, O'Neill D, Lopez R, Pulte D, Ward M, Mantha S, Richardson C.
    Ann N Y Acad Sci; 2005 Jul; 1054():48-54. PubMed ID: 16339651
    [Abstract] [Full Text] [Related]

  • 25. Erythroid marrow activity and functional anemia in patients with the rare interaction of a single functional a-globin and beta-globin gene.
    Traeger-Synodinos J, Papassotiriou I, Vrettou C, Skarmoutsou C, Stamoulakatou A, Kanavakis E.
    Haematologica; 2001 Apr; 86(4):363-7. PubMed ID: 11325640
    [Abstract] [Full Text] [Related]

  • 26. Adeno-associated virus 2-mediated transduction and erythroid lineage-restricted long-term expression of the human beta-globin gene in hematopoietic cells from homozygous beta-thalassemic mice.
    Tan M, Qing K, Zhou S, Yoder MC, Srivastava A.
    Mol Ther; 2001 Jun; 3(6):940-6. PubMed ID: 11407908
    [Abstract] [Full Text] [Related]

  • 27. Molecular biology of hemoglobin: its application to sickle cell anemia and thalassemia.
    Kan YW.
    Schweiz Med Wochenschr Suppl; 1991 Jun; 43():51-4. PubMed ID: 1726857
    [Abstract] [Full Text] [Related]

  • 28. Cellular genomic reporter assays for screening and evaluation of inducers of fetal hemoglobin.
    Vadolas J, Wardan H, Orford M, Williamson R, Ioannou PA.
    Hum Mol Genet; 2004 Jan 15; 13(2):223-33. PubMed ID: 14645208
    [Abstract] [Full Text] [Related]

  • 29. Pharmacologic manipulation of fetal hemoglobin synthesis.
    Dover GJ, Humphries RK, Young N, Ley T, Boyer S, Charache S, Nienhuis A.
    Prog Clin Biol Res; 1985 Jan 15; 191():447-54. PubMed ID: 2413480
    [Abstract] [Full Text] [Related]

  • 30. Cell signaling pathways involved in drug-mediated fetal hemoglobin induction: Strategies to treat sickle cell disease.
    Pace BS, Liu L, Li B, Makala LH.
    Exp Biol Med (Maywood); 2015 Aug 15; 240(8):1050-64. PubMed ID: 26283707
    [Abstract] [Full Text] [Related]

  • 31. Hydroxyurea responses and fetal hemoglobin induction in beta-thalassemia/HbE patients' peripheral blood erythroid cell culture.
    Watanapokasin R, Sanmund D, Winichagoon P, Muta K, Fucharoen S.
    Ann Hematol; 2006 Mar 15; 85(3):164-9. PubMed ID: 16389564
    [Abstract] [Full Text] [Related]

  • 32. Understanding mechanisms of gamma-globin gene regulation to develop strategies for pharmacological fetal hemoglobin induction.
    Pace BS, Zein S.
    Dev Dyn; 2006 Jul 15; 235(7):1727-37. PubMed ID: 16607652
    [Abstract] [Full Text] [Related]

  • 33. Pharmacological Induction of Human Fetal Globin Gene in Hydroxyurea-Resistant Primary Adult Erythroid Cells.
    Chou YC, Chen RL, Lai ZS, Song JS, Chao YS, Shen CK.
    Mol Cell Biol; 2015 Jul 15; 35(14):2541-53. PubMed ID: 25986606
    [Abstract] [Full Text] [Related]

  • 34. Response to hydroxyurea treatment in Iranian transfusion-dependent beta-thalassemia patients.
    Yavarian M, Karimi M, Bakker E, Harteveld CL, Giordano PC.
    Haematologica; 2004 Oct 15; 89(10):1172-8. PubMed ID: 15477200
    [Abstract] [Full Text] [Related]

  • 35. Pharmacologic manipulation of fetal hemoglobin levels in sickle cell diseases and thalassemia: promise and reality.
    Pearson HA.
    Adv Pediatr; 1996 Oct 15; 43():309-34. PubMed ID: 8794181
    [No Abstract] [Full Text] [Related]

  • 36. 5-azacytidine selectively increases gamma-globin synthesis in a patient with beta+ thalassemia.
    Ley TJ, DeSimone J, Anagnou NP, Keller GH, Humphries RK, Turner PH, Young NS, Keller P, Nienhuis AW.
    N Engl J Med; 1982 Dec 09; 307(24):1469-75. PubMed ID: 6183586
    [Abstract] [Full Text] [Related]

  • 37. Stopping the biologic clock for globin gene switching.
    Perrine SP, Faller DV, Swerdlow P, Miller BA, Bank A, Sytkowski AJ, Reczek J, Rudolph AM, Kan YW.
    Ann N Y Acad Sci; 1990 Dec 09; 612():134-40. PubMed ID: 1705405
    [Abstract] [Full Text] [Related]

  • 38. Hemoglobin switching and its clinical implications.
    Blau CA, Stamatoyannopoulos G.
    Curr Opin Hematol; 1994 Mar 09; 1(2):136-42. PubMed ID: 9371272
    [Abstract] [Full Text] [Related]

  • 39. The influence of uridine diphosphate glucuronosyl transferase 1A promoter polymorphisms, beta-globin gene haplotype, co-inherited alpha-thalassemia trait and Hb F on steady-state serum bilirubin levels in sickle cell anemia.
    Adekile A, Kutlar F, McKie K, Addington A, Elam D, Holley L, Clair B, Kutlar A.
    Eur J Haematol; 2005 Aug 09; 75(2):150-5. PubMed ID: 16004608
    [Abstract] [Full Text] [Related]

  • 40. Overview of pathophysiology and rationale for treatment of sickle cell anemia.
    Rodgers GP.
    Semin Hematol; 1997 Jul 09; 34(3 Suppl 3):2-7. PubMed ID: 9317195
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.